SUMMIT THERAP (SMMT)
$19.54
0.25 (1.28%)
SMMT Stock Earnings: Summit Therapeutics Beats EPS for Q2 2024
SMMT stock results show that Summit Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Previous Close
$20.32
Market Cap
14.99B
PE Ratio
-63.42
EPS
-0.3081
Volume (Avg. Vol.)
2.45M
Day's Range
$18.89 - $19.90
52-Week Range
$2.10 - $33.89
Dividend & Yield
N/A (N/A)

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:

Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:

Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?